Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results

Go back to Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results
(NASDAQ: LYEL) Delayed: 12.75 --0 (-0%)
Previous Close $12.75    52 Week High
Open $12.75    52 Week Low
Day High $12.75    P/E N/A 
Day Low $12.75    EPS
Volume 21